Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally advanced head and neck cancer: a randomized phase II trial
PURPOSE: No randomized trials have been conducted to directly compare radiotherapy (RT)
with concomitant cisplatin (CDDP) versus concomitant cetuximab (CTX) as first-line …
with concomitant cisplatin (CDDP) versus concomitant cetuximab (CTX) as first-line …
[HTML][HTML] Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
…, P Borghetti, P Ghirardelli, SM Magrini - British journal of …, 2017 - nature.com
Background: The aim of the present study is to evaluate the impact of metastases-directed
stereotactic body radiotherapy in two groups of oligometastatic prostate cancer (PC) patients: …
stereotactic body radiotherapy in two groups of oligometastatic prostate cancer (PC) patients: …
Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak
AR Filippi, E Russi, SM Magrini, R Corvò - International Journal of …, 2020 - Elsevier
Discussion The COVID-19 spread in Italy was initially subtle and then unexpectedly rapid in
its expansion. Because the first affected regions (especially Lombardia) were characterized …
its expansion. Because the first affected regions (especially Lombardia) were characterized …
[HTML][HTML] Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature
…, P Borghetti, N Pasinetti, R Bresciani, SM Magrini… - Cancers, 2019 - mdpi.com
Anticancer treatment efficacy is limited by the development of refractory tumor cells characterized
by increased expression and activity of mechanisms promoting survival, proliferation, …
by increased expression and activity of mechanisms promoting survival, proliferation, …
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer
PURPOSE: Individual variability in radiosensitivity is large in cancer patients. Single
nucleotide polymorphisms (SNPs) in genes involved in DNA repair and in protection against …
nucleotide polymorphisms (SNPs) in genes involved in DNA repair and in protection against …
[HTML][HTML] Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical …
…, E Simoncini, P Nicolai, G Biti, SM Magrini - European Journal of …, 2012 - Elsevier
BACKGROUND AND PURPOSE: The mechanism of dissemination of locally advanced head
and neck cancer (LAHNC) is far to be resolved. Circulating Tumour Cells (CTC) have been …
and neck cancer (LAHNC) is far to be resolved. Circulating Tumour Cells (CTC) have been …
[HTML][HTML] A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small …
…, F Agustoni, BA Jereczek-Fossa, SM Magrini… - Frontiers in …, 2021 - frontiersin.org
Introduction For unresectable stage III non-small cell lung cancer (NSCLC), the standard
therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for …
therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for …
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
L Triggiani, R Mazzola, SM Magrini, G Ingrosso… - World journal of …, 2019 - Springer
Purpose Herein, we report the clinical outcomes of a multicenter study evaluating the role of
SBRT in a cohort of patients affected by oligoprogressive castration-resistant prostate …
SBRT in a cohort of patients affected by oligoprogressive castration-resistant prostate …
Metastasis-directed therapy (SBRT) guided by PET-CT 18F-CHOLINE versus PET-CT 68Ga-PSMA in castration-sensitive oligorecurrent prostate cancer: a …
…, F Cuccia, L Nicosia, L Livi, SM Magrini… - Clinical Genitourinary …, 2021 - Elsevier
Background The present analysis aims to compare the impact of 18F-fluorocholine ( 18 F-choline)
and gallium-68 prostate-specific membrane antigen ( 68 Ga-PSMA) positron emission …
and gallium-68 prostate-specific membrane antigen ( 68 Ga-PSMA) positron emission …
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the …
S Scoccianti, SM Magrini, U Ricardi, B Detti… - …, 2010 - journals.lww.com
OBJECTIVE: To investigate the pattern of care and outcomes for newly diagnosed
glioblastoma in Italy and compare our results with the previous Italian Patterns of Care study to …
glioblastoma in Italy and compare our results with the previous Italian Patterns of Care study to …